PT  - JOURNAL ARTICLE
AU  - Graf, J.
AU  - Ledala, N.
AU  - Caimano, M. J.
AU  - Jackson, E.
AU  - Gratalo, D.
AU  - Fasulo, D.
AU  - Driscoll, M. D.
AU  - Coleman, S.
AU  - Matson, A.
TI  - Tracking Closely Related Enteric Bacteria at High Resolution in Fecal Samples of Premature Infants Using a Novel rRNA Amplicon
AID  - 10.1101/2020.09.26.20201608
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.26.20201608
4099  - http://medrxiv.org/content/early/2020/09/28/2020.09.26.20201608.short
4100  - http://medrxiv.org/content/early/2020/09/28/2020.09.26.20201608.full
AB  - Identifying and tracking microbial strains as microbiomes evolve is a major challenge in the field of microbiome research. Longitudinal microbiome samples of co-admitted twins from two different neonatal intensive care units (NICUs) were analyzed using a ∼2,500 base amplicon that spans the 16S and 23S rRNA genes, and mapped to a new 16S-23S rRNA database. Amplicon Sequence Variants inferred using DADA2 provided sufficient resolution for differentiation of rRNA variants from closely related, but not previously sequenced Klebsiella, E. coli, and Enterobacter, among the first bacteria colonizing the gut of these infants after admission to the NICU. Distinct ASV groups (fingerprints) were followed between co-admitted twins over time, demonstrating the potential to track the source and spread of both commensals and pathogens.The high-resolution taxonomy obtained from long amplicon sequencing enable tracking of strains temporally and spatially as microbiomes are established in infants in the hospital environment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funds made available through a Connecticut Childrens Medical Center Investigator Award (to AM) and the Stevenson Fund for Microbiome Research, also through Connecticut Childrens Medical Center (also to AM).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Infants were enrolled during 2018 as part of an ongoing neonatal microbiome study approved by the Institutional Review Board at Connecticut Childrens Medical Center.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesStrainID amplicon reads from each fecal sample and each Klebsiella isolate were uploaded to the NCBI BioProject database, with each sample as an indiv`idual file with the appropriate filename. All files were processed to remove contaminating Delftia reads. Annotated whole genome assemblies for K. oxytoca isolates were submitted to the NCBI BioProject database under BioProject accession number PRJNA608440. StrainID amplicon data for this study is deposited under BioProjects PRJNA663638 and PRJNA663575. The accession numbers for the reads are SRR12647577-SRR12647615 and SRR12692773-SRR12692775.